<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02373540</url>
  </required_header>
  <id_info>
    <org_study_id>CLPR 0236</org_study_id>
    <nct_id>NCT02373540</nct_id>
  </id_info>
  <brief_title>Algovita Post-Market Clinical Study: Spinal Cord Stimulation to Treat Chronic Pain</brief_title>
  <official_title>Real-world Evaluation of Outcome Data Under a Prospective, Observational, Post-Market Clinical Study, Using the Algovita SCS System to Treat Patients With Chronic Pain of the Trunk and/or Limbs Per the Applicable Indications for Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nuvectra</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bright Research Partners</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Nuvectra</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to obtain real-world clinical outcome data for the Algovita
      Spinal Cord Stimulation system when used, on-label, according to the applicable directions
      for use.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percent reduction in targeted pain compared to baseline</measure>
    <time_frame>6 Month Follow-up Visit</time_frame>
    <description>Percentage of participants who experience at least a 50 percent reduction in targeted pain from baseline, as assessed by Numeric Rating Scale (NRS). The Numeric Rating Scale (NRS) will range from 0 to 10 with a higher score indicating a higher level of pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent reduction in targeted pain compared to baseline</measure>
    <time_frame>1, 3, 12, 18, and 24 Month Follow-up Visits</time_frame>
    <description>Percentage of participants who experience at least a 50 percent reduction in targeted pain from baseline, as assessed by Numeric Rating Scale (NRS). The Numeric Rating Scale (NRS) will range from 0 to 10 with a higher score indicating a higher level of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent change in targeted pain intensity compared to baseline</measure>
    <time_frame>1, 3, 6, 12, 18, and 24 Month Follow-up Visits</time_frame>
    <description>Percent reduction or actual reduction from baseline in targeted pain intensity, as assessed by Numeric Rating Scale (NRS). The Numeric Rating Scale (NRS) will range from 0 to 10 with a higher score indicating a higher level of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in disability compared to baseline</measure>
    <time_frame>1, 3, 6, 12, 18, and 24 Month Follow-up Visits</time_frame>
    <description>Change from baseline in disability as measured by Oswestry Disability Index (ODI). The Oswestry Disability Index is scored between 0 and 100 with higher scores indicating a greater disability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life compared to baseline</measure>
    <time_frame>1, 3, 6, 12, 18, and 24 Month Follow-up Visits</time_frame>
    <description>Change from baseline in quality of life as measured by EQ-5D, a standardized measure of health status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Willingness to undergo procedure again</measure>
    <time_frame>1, 3, 6, 12, 18, and 24 Month Follow-up Visits</time_frame>
    <description>To record the participants willingness to undergo the procedure again using a question (yes/no) if the participant would be willing to undergo the procedure again.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of device-related and/or procedure-related Adverse Events (AEs)</measure>
    <time_frame>From Implant through 24 Month Follow-up Visit</time_frame>
    <description>To record the rate of device-related and/or procedure-related Adverse Events (AEs).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of surgical intervention of the SCS system</measure>
    <time_frame>From Implant through 24 Month Follow-up Visit</time_frame>
    <description>To record the rate of surgical intervention of the SCS system.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Chronic Pain</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Algovita Spinal Cord Stimulation system</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic, intractable pain of the trunk and/or limbs who are appropriate to
        receive SCS therapy and successfully complete a stimulation trial.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is eligible for SCS therapy according to the Algovita SCS system Indications
             for Use statement

          -  Patient had successful Algovita SCS system stimulation trial with an Algovita SCS
             system and will be implanted with a permanent Algovita SCS system; prior approval must
             be obtained from the Sponsor if another SCS system was used for the stimulation trial

          -  Patient is willing and able to sign an IRB/EC approved informed consent, and in the
             United States, a Privacy Protection Authorization, as required

        Exclusion Criteria:

          -  Patient is contraindicated for an Algovita SCS system

          -  Patient has a cognitive impairment, or exhibits any characteristic, that would limit
             study candidate's ability to assess pain relief or complete study assessments

          -  Patient has a life expectancy of less than 2 years

          -  Patient is participating in another clinical study that would confound data analysis

          -  Patient has a coexisting pain condition that might confound pain ratings
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ben Tranchina</last_name>
    <role>Study Director</role>
    <affiliation>Nuvectra</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hannah Bearinger</last_name>
    <phone>(612) 345-4544</phone>
    <email>Algovita.post-market@nuvectramed.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michele Herzog</last_name>
    <phone>(612) 345-4544</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Summit Healthcare Pain Clinic Associates</name>
      <address>
        <city>Show Low</city>
        <state>Arizona</state>
        <zip>85901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie Amos</last_name>
      <email>jamos@summithealthcare.net</email>
    </contact>
    <investigator>
      <last_name>Dax Trujillo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Coastal Pain and Spinal Diagnostics</name>
      <address>
        <city>Carlsbad</city>
        <state>California</state>
        <zip>92009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzanne Nanson</last_name>
      <email>suzanne@coastalpainresearch.com</email>
    </contact>
    <investigator>
      <last_name>Yogesh Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Samaritan Center for Medical Research</name>
      <address>
        <city>Los Gatos</city>
        <state>California</state>
        <zip>95032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Orr</last_name>
      <email>sdorr@samaritan-research.com</email>
    </contact>
    <investigator>
      <last_name>Maia Chakerian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Restore Orthopedics and Spine Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Greys Belteton</last_name>
      <email>gbelteton@restoreorthopedics.com</email>
    </contact>
    <investigator>
      <last_name>Eric Chang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vitamed Research</name>
      <address>
        <city>Rancho Mirage</city>
        <state>California</state>
        <zip>92270</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chloe Hughes</last_name>
      <email>chloe@vitamedresearch.com</email>
    </contact>
    <investigator>
      <last_name>Tobias Moeller-Bertram, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spine &amp; Nerve Diagnostic Center</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95661</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Surekha Reddy, MD</last_name>
      <email>sreddy@spinenerve.com</email>
    </contact>
    <investigator>
      <last_name>Brian Joves, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Relieve Pain Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chelsea Harkness</last_name>
      <email>charkness@relievepaincenter.com</email>
    </contact>
    <investigator>
      <last_name>Brandon Van Noord, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orthopedic Pain Specialists</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Nona Medical Arts</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32827</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Taneva-Cholakova</last_name>
      <email>etaneva@nonamedicalarts.com</email>
    </contact>
    <investigator>
      <last_name>Richard Gayles, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Florida Clinical Research</name>
      <address>
        <city>South Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damian Sosa</last_name>
      <email>dsosa@sflcresearch.com</email>
    </contact>
    <investigator>
      <last_name>Julian Naranjo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Illinois Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Ephraim McDowell Regional Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Kentucky</state>
        <zip>40422</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyla Anderson</last_name>
      <email>kyla_359@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Anjum Bux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Chestnut Hill</city>
        <state>Massachusetts</state>
        <zip>02467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashish Bhandari</last_name>
      <email>ABHANDARI@BWH.HARVARD.EDU</email>
    </contact>
    <investigator>
      <last_name>Jason Yong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nevada Advanced Pain Specialists</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Garrett Meier</last_name>
      <email>garrett@nvadvancedpain.com</email>
    </contact>
    <investigator>
      <last_name>Denis Patterson, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Garden State Pain Control</name>
      <address>
        <city>Clifton</city>
        <state>New Jersey</state>
        <zip>07013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jordan Weeks</last_name>
      <email>jordanwgardenstatepaincontrol@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Saurabh Dang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Pain Medical Center</name>
      <address>
        <city>Somerset</city>
        <state>New Jersey</state>
        <zip>08873</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>OMNI Pain and Precision Medicine</name>
      <address>
        <city>Utica</city>
        <state>New York</state>
        <zip>13502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary S Sullivan</last_name>
      <email>Mary.Sullivan@killpain.com</email>
    </contact>
    <investigator>
      <last_name>Nameer Haider, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's University Health Network</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pennsylvania Pain and Spine</name>
      <address>
        <city>Chalfont</city>
        <state>Pennsylvania</state>
        <zip>18914</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Acharte, MD</last_name>
      <email>acharte@pennpain.com</email>
    </contact>
    <investigator>
      <last_name>David Qu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Interventional Pain &amp; Spine</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <zip>17601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Universitatksklinikum Dusseldorf</name>
      <address>
        <city>Dusseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>NCN-Neurochirurgische Praxis Neuss</name>
      <address>
        <city>Neuss</city>
        <zip>41460</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabina Piechotta</last_name>
      <email>praxis.wille@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Christian Wille, Prof med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>February 23, 2015</study_first_submitted>
  <study_first_submitted_qc>February 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2015</study_first_posted>
  <last_update_submitted>October 23, 2019</last_update_submitted>
  <last_update_submitted_qc>October 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>spinal cord stimulation</keyword>
  <keyword>chronic pain</keyword>
  <keyword>failed back surgery syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

